Liver transplantation;LA TRANSPLANTATION HEPATIQUE

Presse Medicale

Volumn 25, Issue 4, 1996, Pages 167-170

  Soubrane, O ^a   Houssin, D ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; MISOPROSTOL; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

GENE THERAPY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; SHORT SURVEY; METHODOLOGY; REVIEW; TRANSPLANTATION; XENOGRAFT;

GENE THERAPY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MYCOPHENOLIC ACID; TACROLIMUS; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030567131     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Houssin D, Soubrane O, Boillot O et al Orthotopic liver transplantation with a reduced-size graft, and ideal compromise in pediatrics? Surgery 1992; 111:532-42
2. Soubrane O, Houssin D, Pitre J, Dousset B, Bernard O, Chapuis Y. Extrafascial hyper-reduction of the hepatic graft. J Am Coll Surg 1994, 178:139-43
3. Houssin D, Boillot O, Soubrane O et al Controlled liver splitting for transplantation in two recipients surgical technique, results and perspectives. Br J Surg 1993; 80:75-80.
4. Rogiers X, Buidelski M, Broelsch CE. Liver transplantation from living donors. Br J Surg 1994; 81 1251-3.
5. Soubrane O, Houssin D Recherche « tous azimuts » du greffon en transplantation hépatique. Gastroenterol Clin Biol 1993, 17:845-50.
6. Tzakis A, Todo S, Starzl T. Orthotopic liver transplantation with preservation of the inferior vena cava Ann Surg 1989; 210:649-52.
7. Boudjema K, Cherqui D, Jacck D et al Auxiliary liver transplantation for fulminant and subfulminant hepatic failure Transplantation 1995; 59:218-23.
8. Shaw BW, Markin R, Stratta R et al. FK506 for rescue treatment of acute and chronic rejection in liver allografts recipients. Transplant Proc 1991, 23:2994-5
9. Fung J, Abu-El Magd K, Jain A et al. A randomized trial of primary liver transplantation under immunosuppression with FK506 vs cyclosporin. Transplant Proc 1991; 23 2977-83
10. European KF506 Multicentre Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporiu in prevention of liver allograft rejection Lancet 1994; 344 423-8.
11. Haydon GH, Hayes PC. New immunosuppressive treatment in transplantation medicine. In Clinical gastroenterology gastrointestinal transplantation, Neuberger J ed. Baillière Tindall, London 1994:455-64
12. Samuel D, Muller R, Alexander G et al. Liver transplantation in HBsAg positive patients. A European experience. J Hepatol 1993; 18:S3-4
13. Platt JL, Bach FH The barrier to xenotiansplantation Transplantation 1991; 52:937-47.
14. Houssin D, Weill B. Situation et perspectives des xénogreffes. Presse Med 1993, 22:241-3.
15. Starzl TE, Fung J, Tzakis A et al Baboon- to-human liver transplantation Lancet 1993; 341 65-71.
16. Sussman NL, Chong MG, Koussayer T et al Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16:60-5.
17. Rozga J, Holzman MD, Ro MS et al Development of a hybrid bioartificial liver. Ann Surg 1993; 217:502-11
18. Chari RS, Collins BH, Magee JC et al Treatment of hepatic failure with ex vivo pig liver perfusion followed by liver transplantation. N Engl J Med 1994, 331:234-7.
19. Panis Y, Cardoso J, Houssin D La thérapie génique en hépatologie Résultats expérimentaux et perspectives cliniques Gastroenterol Clin Biol 1994; 18-262-76.